• About
  • Partnerships
  • Challenges
  • Awards
  • Grant Opportunities
  • News

Development of a Glycan Vaccine for Tuberculosis

Glycans are an important component of surface molecules in tuberculosis but their role in protective immunity is still largely unexplored. Carlos Rivera-Marrero and Richard D. Cumming of Emory University in the U.S. will develop high-throughput glycan microarrays to identify glycan antigens, determine their chemical structure, and design glycan-peptide vaccines for future testing.

More information about Create New Vaccines for Diarrhea, HIV, Malaria, Pneumonia, and Tuberculosis (Round 2)

Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

The Bill & Melinda Gates Foundation is part of the Grand Challenges partnership network. Visit www.grandchallenges.org to view the map of awarded grants across this network and grant opportunities from partners.